Detalhe da pesquisa
1.
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: Interrupted time series regression analysis.
Br J Clin Pharmacol
; 87(3): 1129-1140, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668021
2.
A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone.
Br J Clin Pharmacol
; 86(5): 891-902, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833569
3.
Spironolactone use and risk of incident cancers: a retrospective, matched cohort study.
Br J Clin Pharmacol
; 83(3): 653-663, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27735065
4.
PATHWAY-2: spironolactone for resistant hypertension - Authors' reply.
Lancet
; 387(10026): 1373-1374, 2016 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27115814
5.
Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom.
Br J Clin Pharmacol
; 65(5): 775-86, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18279464
6.
Trained dogs identify people with malaria parasites by their odour.
Lancet Infect Dis
; 19(6): 578-580, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31122774
7.
Reducing Arterial Stiffness Independently of Blood Pressure: The VaSera Trial.
J Am Coll Cardiol
; 70(13): 1683-1684, 2017 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935045
8.
Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK.
BJU Int
; 99(4): 860-3, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17378846